This study was designed to investigate the relationship of the expression of cyclin-dependent kinases (CDKs) with theeffects of all-trans retinoic acid (ATRA) on the proliferation of HL-cells. HL-60 cells were treated...This study was designed to investigate the relationship of the expression of cyclin-dependent kinases (CDKs) with theeffects of all-trans retinoic acid (ATRA) on the proliferation of HL-cells. HL-60 cells were treated with ATRA for 1-4 d. Then thecapacity of DNA Synthesis was evaluated with 3H-TdR incorporation and the expression of cyclin E, cyclin D, CDK2 and CDK4protein determined with immunocytochemical staining. In addition, the expression Of CDC2, CDK2 and CDK4 mRNA was deter-mined with in situ hybridization. It was found that ATRA suppressed the proliferation of HL-60 cells and decreased their capacityof DNA synthesis to result in a down-regulation of the expression of cyclin E, cyclin D and CDC2 without comcomittant suppressionon the expression of CDK2 and CDK4. It is concluded that the effects of ATRA on the proliferation of HL-60 cells may be relatedto the down-regulation of the expression of cyclin E, cyclin D and CDC2.展开更多
Cyclin-dependent kinases （CDKs） are critical to the cell cycle and many other biological processes, and as such, are considered as one of the promising targets for therapy against cancer and other diseases. Most pan...Cyclin-dependent kinases （CDKs） are critical to the cell cycle and many other biological processes, and as such, are considered as one of the promising targets for therapy against cancer and other diseases. Most pan-CDK inhibitors bind to the highly conserved catalytic ATP-binding pocket and therefore lack the specificity to prevent side effects. It is desirable to develop drugs targeting non-catalytic pockets for specificity towards individual CDKs. Here we performed a systematic analysis of non-catalytic pockets on CDKs and identified a region underneath the T-loop, which we term TL pocket, for potential inhibitor development. Specifically, we compared the TL pockets of human CDK2 and CDK7-homolog Pfmrk of Plasmodium falciparum, a malaria-causing parasite. Molecular dynamics simulations of several short peptides revealed that this less conserved TL pocket could be used to design potentially specific inhibitors against malaria disease.展开更多
文摘This study was designed to investigate the relationship of the expression of cyclin-dependent kinases (CDKs) with theeffects of all-trans retinoic acid (ATRA) on the proliferation of HL-cells. HL-60 cells were treated with ATRA for 1-4 d. Then thecapacity of DNA Synthesis was evaluated with 3H-TdR incorporation and the expression of cyclin E, cyclin D, CDK2 and CDK4protein determined with immunocytochemical staining. In addition, the expression Of CDC2, CDK2 and CDK4 mRNA was deter-mined with in situ hybridization. It was found that ATRA suppressed the proliferation of HL-60 cells and decreased their capacityof DNA synthesis to result in a down-regulation of the expression of cyclin E, cyclin D and CDC2 without comcomittant suppressionon the expression of CDK2 and CDK4. It is concluded that the effects of ATRA on the proliferation of HL-60 cells may be relatedto the down-regulation of the expression of cyclin E, cyclin D and CDC2.
文摘目的:观察大剂量维生素C对乳腺癌细胞增殖及荷瘤小鼠肿瘤生长的影响,并探索其中的机制。方法:以乳腺癌细胞Bcap37和MDA-MB- 453为体外研究对象,分别给予小(0.01 mmol/L)、中(0.10 mmol/L)、大(2.00 mmol/L)剂量的维生素C。采用CCK-8试剂盒检测细胞增殖;蛋白质印迹法检测葡萄糖转运蛋白1(Glut1)和哺乳动物雷帕霉素靶蛋白(mTOR)信号通路相关蛋白表达;乳酸脱氢酶比色法测定乳酸含量。同时,取10只6周龄雌性BALB/c裸鼠,采用皮下接种乳腺癌Bcap37细胞建立荷瘤小鼠移植瘤模型,取5只小鼠腹腔注射维生素C( 4 g/kg ),观察肿瘤重量和小鼠体质量的变化。结果:体外细胞学实验结果显示,与空白对照组比较,大剂量维生素C作用下Bcap37和MDA-MB- 453细胞增殖受到抑制(均 P < 0.01 ),Glut1转运蛋白表达减少(均 P <0.05),乳酸分泌量减少(均 P < 0.01 ),mTOR信号通路相关蛋白表达水平下调(均 P < 0.05 )。体内实验结果显示,与对照组比较,大剂量维生素C组肿瘤重量明显减小( P <0.05),但体质量增长无明显变化。结论:大剂量维生素C可抑制乳腺癌细胞增殖,这一效果可能与大剂量维生素C抑制乳腺癌细胞能量摄取和下调mTOR信号通路有关。
基金Project supported by the National Natural Science Foundation of China(Grant No.11704140)the Natural Science Foundation of Hubei Province,China(Grant No.2017CFB116)+1 种基金the Thousand Talents Plan(Grant No.31103201603)the Self-determined Research Funds of CCNU from the Colleges’Basic Research and Operation of MOE 20205170045 to YZ
文摘Cyclin-dependent kinases （CDKs） are critical to the cell cycle and many other biological processes, and as such, are considered as one of the promising targets for therapy against cancer and other diseases. Most pan-CDK inhibitors bind to the highly conserved catalytic ATP-binding pocket and therefore lack the specificity to prevent side effects. It is desirable to develop drugs targeting non-catalytic pockets for specificity towards individual CDKs. Here we performed a systematic analysis of non-catalytic pockets on CDKs and identified a region underneath the T-loop, which we term TL pocket, for potential inhibitor development. Specifically, we compared the TL pockets of human CDK2 and CDK7-homolog Pfmrk of Plasmodium falciparum, a malaria-causing parasite. Molecular dynamics simulations of several short peptides revealed that this less conserved TL pocket could be used to design potentially specific inhibitors against malaria disease.
